Greater Achievement of Minimal Disease Activity with Abrocitinib vs Dupilumab: An AHEAD Treat-to-Target Analysis of Patients with Moderate-to-Severe Atopic Dermatitis
Gooderham M, Lio P, Ameen M, Katoh N, Biswas P, Encinas G, Watkins M
AAD 2026
- 美国皮肤病学会年会 2026
| 皮肤病 | 特应性皮炎 | 希必可
Abrocitinib Attenuates Itch-Related Gene Expression in Atopic Dermatitis: Evidence from Lesional and Peri-Lesional Skin Organ Culture and Skin Biopsies from Atopic Dermatitis Patients
Zondler L, Fehrholz M, Pappelbaum K, Piccini I, Edelkamp J, Bertolini M, Watkins M
AAD 2026
- 美国皮肤病学会年会 2026
| 皮肤病 | 特应性皮炎 | 希必可
Real-World Study in Progress: Characterization and Clinical Outcomes of Alopecia Areata Patients Treated With Ritlecitinib in a Real-World Cohort (PRESTO)
Kindred C, Ito T, Wu W, Asfour L, Hebert V, Sadrarhami M, Gauthier G, Bell G, Law E, Soto AG, Martin C, Schaefer G
AAD 2026
- 美国皮肤病学会年会 2026
| 皮肤病 | 斑秃 | 乐复诺
Disease Burden, Treatment Patterns, and Clinical Characteristics of Patients With Alopecia Areata (AA) Treated in United States (US) Community Practices
Sadrarhami M, Gauthier G, Kurosky S, Bell G, Lee YC
AAD 2026
- 美国皮肤病学会年会 2026
| 皮肤病 | 斑秃
